Paladin Wealth LLC boosted its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 32.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,332 shares of the semiconductor company’s stock after buying an additional 327 shares during the quarter. Paladin Wealth LLC’s holdings in Synopsys were worth $683,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of SNPS. Brighton Jones LLC boosted its stake in Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after buying an additional 50 shares in the last quarter. Shell Asset Management Co. boosted its stake in Synopsys by 74.2% in the 4th quarter. Shell Asset Management Co. now owns 2,552 shares of the semiconductor company’s stock valued at $1,239,000 after buying an additional 1,087 shares in the last quarter. Strategic Wealth Partners Ltd. boosted its stake in Synopsys by 16.2% in the 4th quarter. Strategic Wealth Partners Ltd. now owns 1,844 shares of the semiconductor company’s stock valued at $974,000 after buying an additional 257 shares in the last quarter. Stonebrook Private Inc. acquired a new stake in Synopsys in the 4th quarter valued at $353,000. Finally, Troluce Capital Advisors LLC acquired a new stake in Synopsys in the 4th quarter valued at $3,431,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts recently commented on SNPS shares. Morgan Stanley decreased their price target on Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research note on Thursday. Robert W. Baird reissued a “neutral” rating and issued a $535.00 price objective (down previously from $670.00) on shares of Synopsys in a research note on Wednesday, September 10th. Baird R W lowered Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Rosenblatt Securities reissued a “neutral” rating and issued a $605.00 price objective (down previously from $650.00) on shares of Synopsys in a research note on Wednesday, September 10th. Finally, Wall Street Zen lowered Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday. Eleven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Synopsys presently has a consensus rating of “Moderate Buy” and an average target price of $585.33.
Synopsys Trading Down 2.9%
Shares of SNPS opened at $425.45 on Monday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The firm has a market capitalization of $79.03 billion, a PE ratio of 33.39, a price-to-earnings-growth ratio of 5.60 and a beta of 1.14. The stock’s fifty day simple moving average is $590.39 and its 200-day simple moving average is $507.16.
Insider Activity
In other news, CRO Richard S. Mahoney sold 9,010 shares of the company’s stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the transaction, the executive owned 1,485 shares of the company’s stock, valued at $699,746.85. This represents a 85.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total value of $6,694,687.66. Following the transaction, the chief executive officer directly owned 71,615 shares in the company, valued at $42,181,951.15. This trade represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 24,031 shares of company stock valued at $13,168,999 over the last 90 days. 0.62% of the stock is owned by company insiders.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Best Stocks Under $10.00
- Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside
- 3 Monster Growth Stocks to Buy Now
- Football Season Is Here and DraftKings Stock Is Surging
- What is Put Option Volume?
- RH Stock Slides After Mixed Earnings and Tariff Concerns
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.